Atovaquone Suspension Compared with Aerosolized Pentamidine for Prevention ofPneumocystis cariniiPneumonia in Human Immunodeficiency Virus–Infected Subjects Intolerant of Trimethoprim or Sulfonamides
Open Access
- 1 August 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 180 (2) , 369-376
- https://doi.org/10.1086/314893
Abstract
Atovaquone suspensions (750 mg and 1500 mg once a day) were compared with aerosolized pentamidine (300 mg once a month) for the prevention of PneumocKeywords
This publication has 0 references indexed in Scilit: